Shivaprasad H. Sathyanarayana, Michelle A. Bickford, Narcisa A. Smuliac, Kyle A. Tonseth, Farzana Murad, Jing Bao, Heather B. Steinmetz, Matthew R. Sullivan, Prabhjot Kaur, Jeremiah X. Karrs, Wahab A. Khan
{"title":"19.高分辨率细胞基因组分析揭示了 APL 样白血病的特征性异常","authors":"Shivaprasad H. Sathyanarayana, Michelle A. Bickford, Narcisa A. Smuliac, Kyle A. Tonseth, Farzana Murad, Jing Bao, Heather B. Steinmetz, Matthew R. Sullivan, Prabhjot Kaur, Jeremiah X. Karrs, Wahab A. Khan","doi":"10.1016/j.cancergen.2024.08.021","DOIUrl":null,"url":null,"abstract":"<div><div>We report comprehensive characterization of cytogenomic findings from a bone marrow sample with suspected acute promyelocytic leukemia (APL) based on morphology and immunophenotype. Fluorescence <em>in situ</em> hybridization (FISH) and chromosome banding analysis (CBA) were negative for canonical <em>PML::RARA</em> and variant <em>RARA</em> translocations. PCR was negative for increased <em>PML::RARA</em> transcripts. CBA analysis detected loss of 5q, 17p as well as double minutes (dmin). To further rule out other retinoic acid receptor (RAR) partners, such as <em>RARB, RARG</em>, and identify the dmin, we employed genome-wide structural variant analysis (gSVA) using optical genome mapping. Interestingly, gSVA unmasked the dmin to be of <em>MYC</em> origin with ∼44 copies; this abnormality has been reported in APL-like leukemia and explained the immunophenotype. gSVA also identified loss of <em>TP53</em>, loss of chromosomes 1, 2, 8, 9 (includes <em>CDKN2A</em>), 10, and 11 along with gains of chromosomes 3, 6, 7, and 15 as separate clonal events.</div><div>No additional RAR partner translocations were observed. gSVA also showed a complex translocation, adjacent to 3Mb euploid region of 17p, in a rearrangement with chromosome 5, fusing genes <em>DMGDH-AKAP10</em>. As part of the testing algorithm, heme exome-based panel analysis detected a Tier I deleterious variant in <em>TP53</em> (p.S241C). A 4-month follow up bone marrow again analyzed by gSVA, post induction therapy, showed a reduction in <em>MYC</em> amplification (∼4 copies). This work helped explain the APL-like phenotype for this rare leukemia in an initially emergent situation, provided a marker for follow-up testing, and merits integrated genomic analysis of similar cases.</div></div>","PeriodicalId":49225,"journal":{"name":"Cancer Genetics","volume":"286 ","pages":"Pages S6-S7"},"PeriodicalIF":1.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"19. High resolution cytogenomic analysis reveals characterizing abnormalities in APL-like leukemia\",\"authors\":\"Shivaprasad H. Sathyanarayana, Michelle A. Bickford, Narcisa A. Smuliac, Kyle A. Tonseth, Farzana Murad, Jing Bao, Heather B. Steinmetz, Matthew R. Sullivan, Prabhjot Kaur, Jeremiah X. Karrs, Wahab A. Khan\",\"doi\":\"10.1016/j.cancergen.2024.08.021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>We report comprehensive characterization of cytogenomic findings from a bone marrow sample with suspected acute promyelocytic leukemia (APL) based on morphology and immunophenotype. Fluorescence <em>in situ</em> hybridization (FISH) and chromosome banding analysis (CBA) were negative for canonical <em>PML::RARA</em> and variant <em>RARA</em> translocations. PCR was negative for increased <em>PML::RARA</em> transcripts. CBA analysis detected loss of 5q, 17p as well as double minutes (dmin). To further rule out other retinoic acid receptor (RAR) partners, such as <em>RARB, RARG</em>, and identify the dmin, we employed genome-wide structural variant analysis (gSVA) using optical genome mapping. Interestingly, gSVA unmasked the dmin to be of <em>MYC</em> origin with ∼44 copies; this abnormality has been reported in APL-like leukemia and explained the immunophenotype. gSVA also identified loss of <em>TP53</em>, loss of chromosomes 1, 2, 8, 9 (includes <em>CDKN2A</em>), 10, and 11 along with gains of chromosomes 3, 6, 7, and 15 as separate clonal events.</div><div>No additional RAR partner translocations were observed. gSVA also showed a complex translocation, adjacent to 3Mb euploid region of 17p, in a rearrangement with chromosome 5, fusing genes <em>DMGDH-AKAP10</em>. As part of the testing algorithm, heme exome-based panel analysis detected a Tier I deleterious variant in <em>TP53</em> (p.S241C). A 4-month follow up bone marrow again analyzed by gSVA, post induction therapy, showed a reduction in <em>MYC</em> amplification (∼4 copies). This work helped explain the APL-like phenotype for this rare leukemia in an initially emergent situation, provided a marker for follow-up testing, and merits integrated genomic analysis of similar cases.</div></div>\",\"PeriodicalId\":49225,\"journal\":{\"name\":\"Cancer Genetics\",\"volume\":\"286 \",\"pages\":\"Pages S6-S7\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Genetics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2210776224000590\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Genetics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210776224000590","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
19. High resolution cytogenomic analysis reveals characterizing abnormalities in APL-like leukemia
We report comprehensive characterization of cytogenomic findings from a bone marrow sample with suspected acute promyelocytic leukemia (APL) based on morphology and immunophenotype. Fluorescence in situ hybridization (FISH) and chromosome banding analysis (CBA) were negative for canonical PML::RARA and variant RARA translocations. PCR was negative for increased PML::RARA transcripts. CBA analysis detected loss of 5q, 17p as well as double minutes (dmin). To further rule out other retinoic acid receptor (RAR) partners, such as RARB, RARG, and identify the dmin, we employed genome-wide structural variant analysis (gSVA) using optical genome mapping. Interestingly, gSVA unmasked the dmin to be of MYC origin with ∼44 copies; this abnormality has been reported in APL-like leukemia and explained the immunophenotype. gSVA also identified loss of TP53, loss of chromosomes 1, 2, 8, 9 (includes CDKN2A), 10, and 11 along with gains of chromosomes 3, 6, 7, and 15 as separate clonal events.
No additional RAR partner translocations were observed. gSVA also showed a complex translocation, adjacent to 3Mb euploid region of 17p, in a rearrangement with chromosome 5, fusing genes DMGDH-AKAP10. As part of the testing algorithm, heme exome-based panel analysis detected a Tier I deleterious variant in TP53 (p.S241C). A 4-month follow up bone marrow again analyzed by gSVA, post induction therapy, showed a reduction in MYC amplification (∼4 copies). This work helped explain the APL-like phenotype for this rare leukemia in an initially emergent situation, provided a marker for follow-up testing, and merits integrated genomic analysis of similar cases.
期刊介绍:
The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.